Aldeyra Therapeutics Inc’s filing revealed that its Chief Development Officer Machatha Stephen unloaded Company’s shares for reported $75975.0 on Aug 12 ’24. In the deal valued at $4.74 per share,16,041 shares were sold. As a result of this transaction, Machatha Stephen now holds 236,771 shares worth roughly $1.12 million.
Then, Greenberg Bruce sold 10,834 shares, generating $51,313 in total proceeds. Upon selling the shares at $4.74, the insider now owns 126,382 shares.
Before that, Greenberg Bruce bought 10,834 shares. Aldeyra Therapeutics Inc shares valued at $55,253 were divested by the Officer at a price of $5.10 per share.
Oppenheimer upgraded its Aldeyra Therapeutics Inc [ALDX] rating to an Outperform from a a Perform in a research note published recently. H.C. Wainwright started covering the stock on February 08, 2021. It rated ALDX as “a Buy”.
Price Performance Review of ALDX
On Tuesday, Aldeyra Therapeutics Inc [NASDAQ:ALDX] saw its stock fall -0.73% to $4.75. Over the last five days, the stock has lost -9.38%. Aldeyra Therapeutics Inc shares have risen nearly 37.61% since the year began. Nevertheless, the stocks have risen 38.79% over the past one year. While a 52-week high of $6.55 was reached on 09/05/24, a 52-week low of $2.71 was recorded on 03/15/24. SMA at 50 days reached $5.11, while 200 days put it at $4.49.
Levels Of Support And Resistance For ALDX Stock
The 24-hour chart illustrates a support level at 4.67, which if violated will result in even more drops to 4.59. On the upside, there is a resistance level at 4.83. A further resistance level may holdings at 4.91. The Relative Strength Index (RSI) on the 14-day chart is 45.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.23, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.24%. Stochastics %K at 16.14% indicates the stock is a buying.
How much short interest is there in Aldeyra Therapeutics Inc?
A steep rise in short interest was recorded in Aldeyra Therapeutics Inc stocks on 2024-11-29, dropping by -0.25 million shares to a total of 3.41 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 3.67 million shares. There was a decline of -7.42%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 16, 2020 when Berenberg began covering the stock and recommended ‘”a Buy”‘ rating along with a $32 price target.
